NewCardio, Inc.

OTC: NWCI · Healthcare · Medical - Devices

PublicHQ Branchburg, NJReports USD

#972 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 36

v0.1 · 5/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ Altman-Z, market scale

Methodology →

Revenue TTM

$238.6k

Rev growth YoY (TTM)

+40.9%

Net income (FY)

-$11.5M

Employees

Market cap

$3.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$257.4k$257.4k2010

Net income-$11.5M-$11.5M2010

Operating income-$9.5M-$9.5M2010

Total assets$2.9M$2.9M2010

Liabilities$6.0M$6.0M2010

Equity-$3.2M-$3.2M2010

Revenue trend

FY2004 – FY2010 · USD

$461.6k

FY04

$1.0M

FY05

FY06

FY07

FY08

FY09

$257.4k

FY10

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

NewCardio, Inc. booked $257.4k in FY2010 revenue — among the slowest-growing Healthcare companies we track, at a -4466.2% net margin.

Peers · Healthcare

New York Health Care, Inc.——Rebus Holdings, Inc.——Regen BioPharma, Inc.37D Sproutly Canada Inc.——

Key facts

CEOJess Emery Jones

SectorHealthcare

IndustryMedical - Devices

HeadquartersBranchburg, NJ

ExchangeOTC: NWCI

Employees10

IPO date2008-01-04

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.